Labshake search
Citations for R&D Systems :
651 - 700 of 10000+ citations for Recombinant Human ERBB2 protein Fc tagged R PE labeled since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Physiology 2023Quote: ... ciCMVEC were placed in serum-free media 1h before treatment with 10 ng/ml of Recombinant Human TNF-α Protein (210-TA-005; R&D systems) or vehicle (PBS ...
-
bioRxiv - Bioengineering 2024Quote: ... IDUA activity was assessed using 4-methylumberlliferyl-alpha-L-iduronide (Glycosynth, Cheshire, England) and recombinant human alpha-L-iduronidase protein (R&D systems, Minneapolis) following manufacturer’s instructions.
-
bioRxiv - Cancer Biology 2024Quote: ... and 5% fetal Bovine serum (Hyclone, #SH300084) and treatment with 2.5 ng/ml of recombinant Human TGF-β 1 Protein (R&D systems, #RDS240B002) for maximum of 18 days ...
-
bioRxiv - Cancer Biology 2024Quote: ... cells were cultured in media containing 2% FBS and treated with recombinant human Wnt-3a protein (R&D systems, Cat# 5036-WN-010) at a final concentration of 200ng/mL for 2h.
-
bioRxiv - Bioengineering 2021Quote: Recombinant human IDO expressed in Escherichia coli was purchased from R&D Systems (Minneapolis, MN) with a predicted molecular mass of 46 kDa a specific activity of >500pmoles/min/μg (or for equimolar calculations >29 pmol NFK/min/pmol IDO ...
-
bioRxiv - Microbiology 2020Quote: ... infected HFF monolayers were stimulated with 100U/mL recombinant human IFN-γ (R&D Systems) 24 hours post-infection and fixed 6 hours post-stimulation ...
-
bioRxiv - Cancer Biology 2020Quote: ... CMK lines were treated with 200 ng/ml of recombinant human WNT3A (R&D systems) for 4 hours ...
-
bioRxiv - Cancer Biology 2021Quote: ... 10 ng ml−1 of recombinant human TNFα (R&D Systems, 210-TA-020/CF) or a combination of both ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 ng/ml recombinant human NRG1-β 1 (#396-HB, R&D Systems, USA) as described in Poitelon et al ...
-
bioRxiv - Molecular Biology 2022Quote: Human recombinant BMP-2 and BMP-4 were purchase from R&D Systems (Minneapolis, MN). Anti-Myc and anti-HA antibodies were purchased from Cell Signaling Technology (Danvers ...
-
bioRxiv - Cell Biology 2022Quote: ... Recombinant human versican isoform V3 and lumican were from R&D Systems (Minneapolis, MN, USA). Recombinant human versican protein G1 and G3 domains (ab152303 and ab236178 ...
-
bioRxiv - Molecular Biology 2020Quote: Mice fibroblast cells (FLS) treated with 5 ng/mL recombinant human TNF (R&D Systems) for 16 hours were harvested at 95% confluence ...
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant epidermal growth factor (20 ng/ml; #236-EG-01M, R&D systems, USA), human recombinant fibroblast growth factor (20 ng/ml ...
-
bioRxiv - Immunology 2020Quote: ... Monocytes were stimulated for 18hrs with 100U/mL recombinant human IFN-β (R&D systems) and processed for RNA extraction.
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems; Bio-techne, Inc.) until use.
-
bioRxiv - Physiology 2020Quote: ... with 2 µg of recombinant human TSG-6 (rTSG-6, R&D Systems, Minneapolis, MN) in 100 µl PBS (or with PBS alone ...
-
bioRxiv - Genetics 2020Quote: ... base medium supplemented with 50 ng/ml recombinant human SCF (R&D systems #255-SC), 1 μg/ml doxycycline (Sigma Aldrich #D9891) ...
-
bioRxiv - Biochemistry 2021Quote: ... recombinant human CD45 (cat no. 1430-CD-050) was from R&D Systems (Minneapolis, MN), recombinant human CD45 (cat no ...
-
bioRxiv - Cell Biology 2020Quote: ... with 25 ng/ml recombinant human WNT3A (R&D Systems, cat. no. 5036-WN-010) and 100 ng/ml Activin A (Humanzyme ...
-
bioRxiv - Immunology 2020Quote: ... Recombinant human IL-15 and mouse IL-21 were from R&D Systems (Minneapolis, MN).
-
bioRxiv - Cancer Biology 2022Quote: ... Cells were treated with 5 ng/mL recombinant human TGFβ1 (R&D Systems, 240-B) prepared according to the manufacture’s specifications ...
-
bioRxiv - Microbiology 2024Quote: ... BChE activity was analogously measured using 5 ng of recombinant human BChE (R&D Systems) and butyrylthiocholine iodide ...
-
bioRxiv - Immunology 2024Quote: ... IL-12 and recombinant human TGF-β1 were purchased from R&D Systems (Abingdon, UK).
-
bioRxiv - Neuroscience 2023Quote: ... Recombinant human TGF-β2 (Cat# 302-B2-002/CF) was purchased from R&D Systems.
-
bioRxiv - Bioengineering 2022Quote: ... supplemented with 50 ng/mL recombinant human vascular endothelial growth factor (VEGF; R&D Systems), 10 μM Y-27632 ...
-
bioRxiv - Cell Biology 2022Quote: ... they and their controls were treated with recombinant human CXCL12 (R&D Systems, #350-NS) in a biopolymer delivery vehicle (CellMate3D ...
-
bioRxiv - Immunology 2022Quote: ... or 10 ng/mL of recombinant human IL-1β (R&D Systems; 201-LB-005) for the indicated times ...
-
bioRxiv - Neuroscience 2023Quote: ... supplemented with 20 ng/mL recombinant human basic FGF (#233-FB, R&D Systems, Germany) and 10 µM Y-27632 (only for the first 24 h after passaging ...
-
bioRxiv - Systems Biology 2023Quote: ... with 10% Fetal Bovine Serum and 100ng/ml recombinant Human M-CSF (R&D Systems) for 4 days.
-
bioRxiv - Developmental Biology 2023Quote: ... with 25 ng/ml of recombinant human VEGF-C (Cat#: 9199-VC, R&D Systems) and HUVECs were cultured in complete Endothelial Cell Growth Medium (ECGM ...
-
bioRxiv - Genomics 2023Quote: ... (Thermo Fisher Scientific)] medium supplemented with recombinant human/mouse/rat activin A (100 ng/mL; R&D Systems) for 18 hours ...
-
bioRxiv - Immunology 2024Quote: ... cells were stimulated with 1 ng/mL of recombinant human TGF-β1 (R&D Systems), 10 ng/mL of recombinant mouse IL-4 (R&D Systems ...
-
bioRxiv - Immunology 2024Quote: ... recombinant Human IL-2 (R&D Systems, catalog no. 202-GMP or BT-002-GMP) was supplemented at 200 IU/mL ...
-
bioRxiv - Genomics 2024Quote: ... and 1 ng/mL recombinant human interleukin IL-3 (R&D systems, 203-IL/CF). Phase 2 includes phase 1 media without IL-3 and phase 3 includes phase 1 media without IL-3 and SCF with holo-transferrin increased to 1 mg/mL final concentration ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... Recombinant Human FGF2 (Cat# 233-FB-010) was purchased from R&D Systems (Minneapolis, MN). FIIN-2 (Cat# S7714 ...
-
bioRxiv - Biophysics 2024Quote: ... 50 nM recombinant carrier free human Wnt3a (R&D Systems Inc., 5036-WN-010/CF) and/or human Wnt5a (R&D Systems Inc. ...
-
bioRxiv - Immunology 2020Quote: Titration of blocking antibodies was performed by using static adhesion assays in which activated CD4+ T cells were allowed to adhere to either recombinant human ICAM/Fc or VCAM/Fc chimeras in the presence of blocking antibodies specific for integrin α4 (clone 2B4, R&D Systems) or integrin αL (clone TS1/22 ...
-
bioRxiv - Microbiology 2023Quote: ... Cells were then incubated for 5 minutes on ice with a mixture of soluble human IgG1-Fc fused Eph receptor/s (150 nM sEphB2-Fc (R&D systems) for the first scan or 1 μM sEphB3-Fc plus 1μM sEphB4-Fc for the second scan ...
-
bioRxiv - Immunology 2022Quote: ... or plate-bound CD155-Fc chimera protein (CD155-IEGRMDP-Mouse IgG2a; R&D Systems). For plate coating with Abs or Fc ...
-
bioRxiv - Molecular Biology 2022Quote: ... for Tie2 IP or Tie2-Fc fusion protein (R&D Systems, cat. #313-TI) for COMP-Ang1 IP were covalently coupled to M-270 Epoxy Dynabeads™ (Thermo Scientific) ...
-
bioRxiv - Immunology 2020Quote: ... mouse ICAM1-Fc (R&D systems), FxCycle Violet Stain ...
-
bioRxiv - Cancer Biology 2023Quote: ... EphrinB1-Fc (R&D systems, USA) and control Fc fragment (R&D Systems ...
-
bioRxiv - Microbiology 2024Quote: ... FcRn (R&D Systems 8639-FC) and 8E7 (Bio-Rad MCA2716 ...
-
bioRxiv - Immunology 2020Quote: ... CA) with 1% human serum and 1,200 IU/ml of recombinant human interleukin-2 (R&D Systems, Inc., Minneapolis, MN). As a positive control ...
-
bioRxiv - Pathology 2023Quote: The ROSAKIT WT human cell line (RRID:CVCL_5G49) was cultured in the presence of recombinant human SCF (80 ng/mL, R&D Systems), as described previously (23) ...
-
bioRxiv - Neuroscience 2020Quote: ... cells were preincubated for 10min with 30µg rat anti-human neuropilin1 Fc chimera (R&D System) or 20µg goat anti-human neuropilin2 Fc chimera (R&D System ...
-
bioRxiv - Developmental Biology 2023Quote: ... a fusion of mNope ECD (G22-H953) to human Fc (Biotechne R&D Systems 1394-NP), and a fusion of mPrtg ECD (F36-A952 ...
-
bioRxiv - Immunology 2020Quote: ... 20µg/mL IL-21 R Fc Chimera (R&D Systems) was used.
-
bioRxiv - Cell Biology 2022Quote: ... Experiments were done in 293T cells pretreated with 5 ng/ml recombinant human R-spondin 3 (R&D Systems, Minneapolis, USA). Experiments were performed with biological triplicates ...
-
bioRxiv - Cancer Biology 2021Quote: Recombinant mouse MMP-12 protein (3467-MPB-020) was purchased from R&D Systems, Inc ...